Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 5:8:658687.
doi: 10.3389/fmolb.2021.658687. eCollection 2021.

A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike Protein

Affiliations

A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike Protein

Maria Luisa Di Vona et al. Front Mol Biosci. .

Abstract

Many current strategies for inducing an immune response rely on the production of an antigenic protein. Such methods can be problematic if the folding of the antigenic protein is incorrect. To avoid this problem, we propose a method based on grafting specific regions of the chosen antigenic protein onto biocompatible polymeric matrices, so that they can mimic portions of the antigenic protein. These regions are selected following the criterion according to which they are not folded, are exposed to the solvent and are not already present in the human body, so that they are not recognized by the immune system as self. Regions are selected using the primary sequence of the protein and, where possible, its tertiary structure. The application of this strategy to the Spike protein of SARS-CoV-2 is presented.

Keywords: COVID-19; SARS-CoV-2; bioconjugate polymers; hybrid protein-polymer; loop regions.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Location of the proposed regions in the Spike protein and comparison with Spike proteins from other coronavirus. (A) Top: schematic view of the Spike protein with the specifications of the different domains: NTD, N-Terminal Domain; RBD, Receptor Binding Domain; RBM, Receptor Binding Motif; FP, Fusion Peptide; HR1, Heptad Repeat 1; HR2, Heptad Repeat 2; TM, TransMembrane region; CP, Cytoplasmic Domain. The S1 domain consists of the NTD and RBD regions. Bottom: primary sequence of Spike protein in SARS-CoV-2 in the prefusion state (Wrapp et al., 2020; PDB code 6vsb, chain A). Helices are colored in yellow, sheets are colored in green and the missing regions in the crystal structure are colored in blue. The regions reported in the text are underlined. (B) 3D structure of Spike protein in SARS-CoV-2 in the prefusion state (Wrapp et al., 2020; PDB code 6vsb) where the regions reported in the text are colored in green for each monomer. (C) 3D structure of Spike protein in MERS-CoV in the prefusion state (Yuan et al., 2017; PDB code 5 × 5c). The regions corresponding to the ones reported in text are colored in green for each monomer. (D) 3D structure of Spike protein in SARS-CoV in the prefusion state (Yuan et al., 2017; PDB code 5 × 58). The regions corresponding to the ones reported in text are colored in green for each monomer. The equivalent residues in MERS-CoV and SARS-CoV were obtained by multiple alignment using the ClustalW software (Larkin et al., 2007). The figures were prepared with Chimera software (Pettersen et al., 2004).

References

    1. Alibeik S., Sask K. N. (2019). “Blood compatible polymers,” in Functional Biopolymers Polymers and Polymeric Composites: A Reference Series, eds Jafar Mazumder M. A., Sheardown H., Al-Ahmed A. (Cham: Springer International Publishing; ), 149–189. 10.1007/978-3-319-95990-0_3 - DOI
    1. Azoitei M. L., Ban Y.-E. A., Julien J.-P., Bryson S., Schroeter A., Kalyuzhniy O., et al. (2012). Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope. J. Mol. Biol. 415 175–192. 10.1016/j.jmb.2011.10.003 - DOI - PMC - PubMed
    1. Broyer R. M., Grover G. N., Maynard H. D. (2011). Emerging synthetic approaches for protein–polymer conjugations. Chem. Commun. 47 2212–2226. 10.1039/C0CC04062B - DOI - PMC - PubMed
    1. Chandrudu S., Bartlett S., Khalil Z. G., Jia Z., Hussein W. M., Capon R. J., et al. (2016). Linear and branched polyacrylates as a delivery platform for peptide-based vaccines. Ther. Deliv. 7 601–609. 10.4155/tde-2016-0037 - DOI - PubMed
    1. Chen C., Ng D. Y. W., Weil T. (2020). Polymer bioconjugates: modern design concepts toward precision hybrid materials. Progr. Polym. Sci. 105:101241. 10.1016/j.progpolymsci.2020.101241 - DOI